# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-16-109504
Filing Date
2016-06-23
Accepted
2016-06-23 16:37:46
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | v442814_424b3.htm | 424B3 | 2612247
2 | GRAPHIC | line.gif | GRAPHIC | 43
3 | GRAPHIC | logo.jpg | GRAPHIC | 2594
4 | GRAPHIC | sig_jcook.jpg | GRAPHIC | 20197
5 | GRAPHIC | spacer.gif | GRAPHIC | 43
6 | GRAPHIC | tex5-1logo.jpg | GRAPHIC | 9464
7 | GRAPHIC | tex99-1logo.jpg | GRAPHIC | 13863
8 | GRAPHIC | v439550_proxycard-1.jpg | GRAPHIC | 1085956
9 | GRAPHIC | v439550_proxycard-2.jpg | GRAPHIC | 704665
| Complete submission text file | 0001144204-16-109504.txt |  | 5143679

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-193458 | Film No.: 161728995
SIC: 2836 Biological Products, (No Diagnostic Substances)